1. International Symposium of Tokyo University of Science, Translational Research (TR) Center —Frontiers in Developmental Strategy for Cancer Therapeutics—
Date：October 20 (Saturday), 2018 　10: :00
Venue：Fujimi Bilding, Kagurazaka Campus, Tokyo University of Science, Japan
10:30 ~ 10:40 Opening Remarks
　　　　　　　 Soichiro Okamura, Vice-President, Tokyo University of Science
10:40 ~ 11:20 Invited Lecture 1 　
“Role of exosomal microRNAs in the biology of the Tumor Microenvironment ”
Muller Fabbri., Ph.D., University of Hawaii
11:20 ~ 11:50
“Obesity and intestinal cancer development”　
Michihiro Mutoh, M.D., Ph.D., National Cancer Center, Japan
11:50 ~ 13:10 Lunch Break
13:10 ~ 13:40
“Design and Development of Nano and Cell Medicine for Cancer Therapy”
Makiya Nishikawa, Ph.D., Tokyo University of Science
13:40 ~ 14:10
“Development of a novel therapeutic strategy for poor prognostic breast cancer by PARP1 degradation mechanism”
Yoshikazu Higami, M.D., Ph.D., Tokyo University of Science
14:10 ~ 14:40
“Establishment of gastric cancer patient-derived xenografts (PDX) and cell lines”
Takeshi Kuwata, M.D., Ph.D., National Cancer Center Hospital East, Japan
14:40 ~ 16:10 Coffee Break & Poster Session
16:10 ~ 16:50 Invited Lecture 2
“Azetidine-based small molecule inhibitors of STAT3 for treating triple negative breast cancer”
James Turkson, Ph.D., University of Hawaii
16:50 ~ 17:20
“Development of New Methods for Cancer Theranostics in Interdisciplinary Collaboration of Tokyo University of Science”
Shin Aoki, Ph.D., Tokyo University of Science 
17:20 ~ 17:25 Closing Remarks
17:30 ~ 19:00 Banquet
Supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities,
＜Symposium Office＞ Prof. Takehisa Hanawa, TR Center, Research Institute for Science and Technology, Tokyo University of Science
(Yayoi Kawano, Ph.D.)